Cargando…

A Founder Mutation of the BRCA1-Gene in Western Sweden

Detalles Bibliográficos
Autores principales:	Einbeigi, Zakaria, Kindblom, Jeane, Kindblom, Lars-Gunnar, Martinsson, Tommy, Suurkula, Mart, Wahlström, Jan, Wallgren, Arne, Karlsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 1999
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851060/ http://dx.doi.org/10.1155/1999/391792

Ejemplares similares

Increased Overall Mortality Even after Risk Reducing Surgery for BRCA-Positive Women in Western Sweden
por: Öfverholm, Anna, et al.
Publicado: (2019)

Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018
por: Nyqvist, Jenny, et al.
Publicado: (2020)

Incidence and Characteristics in Children with Post–COVID-19 Condition in Sweden
por: Bygdell, Maria, et al.
Publicado: (2023)

Founder BRCA1 mutations in Nepalese population
por: Mehta, Anurag, et al.
Publicado: (2022)

Identification of a founder BRCA2 mutation in Sardinia
por: Pisano, M, et al.
Publicado: (2000)

Evidence of a founder BRCA1 mutation in Scotland
por: Liede, A, et al.
Publicado: (2000)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

Primary spinal intradural mesenchymal chondrosarcoma with detection of fusion gene HEY1-NCOA2: A paediatric case report and review of the literature
por: ANDERSSON, CAROLA, et al.
Publicado: (2014)

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
por: Maksimenko, J., et al.
Publicado: (2018)

BRCA1 founder mutations compared to ovarian cancer in Belarus
por: Savanevich, Alena, et al.
Publicado: (2014)

Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—A cohort study
por: Sjögren, Lovisa, et al.
Publicado: (2021)

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
por: Vazina, A, et al.
Publicado: (2000)

Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
por: Caleca, Laura, et al.
Publicado: (2014)

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
por: Solano, Angela R., et al.
Publicado: (2018)

The Icelandic founder mutation BRCA2 999del5: analysis of expression
por: Mikaelsdottir, Evgenia K, et al.
Publicado: (2004)

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)
por: Nilsson, B, et al.
Publicado: (2007)

A secular trend of increasing pubertal BMI change among Swedish adolescents
por: Bygdell, Maria, et al.
Publicado: (2021)

BRCA1 4153delA founder mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2006)

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile
por: Alvarez, Carolina, et al.
Publicado: (2017)

The Features of BRCA1 and BRCA2 Germline Mutations in Hakka Ovarian Cancer Patients: BRCA1 C.536 A>T Maybe a Founder Mutation in This Population
por: Luo, Yu, et al.
Publicado: (2022)

A mutation in POLE predisposing to a multi-tumour phenotype
por: ROHLIN, ANNA, et al.
Publicado: (2014)

Defined daily doses in pediatric dosing‐ a theoretical example
por: Dahlén, Elin, et al.
Publicado: (2023)

Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders
por: Inerot, Annica, et al.
Publicado: (2005)

Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G
por: Claes, Kathleen, et al.
Publicado: (1999)

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
por: Hamel, Nancy, et al.
Publicado: (2003)

BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
por: Ławniczak, Małgorzata, et al.
Publicado: (2016)

Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity
por: Bu, Rong, et al.
Publicado: (2023)

BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study
por: Kowalik, Artur, et al.
Publicado: (2018)

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
por: Kluz, Tomasz, et al.
Publicado: (2018)

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
por: Kringen, Pedro, et al.
Publicado: (2005)

Age at Adiposity Rebound Is Associated with Fat Mass in Young Adult Males—The GOOD Study
por: Ohlsson, Claes, et al.
Publicado: (2012)

Early puberty and risk for type 2 diabetes in men
por: Ohlsson, Claes, et al.
Publicado: (2020)

Clot-Bey: founder of western medical practice in Egypt.
por: Burrow, G. N.
Publicado: (1975)

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients
por: Bümming, P, et al.
Publicado: (2003)

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
por: Janavičius, Ramūnas
Publicado: (2010)

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
por: Behl, Supriya, et al.
Publicado: (2020)

BRCA Genetic Screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (c.798_799delTT) in North African
por: Laraqui, Abdelilah, et al.
Publicado: (2015)

Revisiting the critical weight hypothesis for regulation of pubertal timing in boys
por: Bygdell, Maria, et al.
Publicado: (2020)

Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding
por: Braide, K., et al.
Publicado: (2020)

Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis
por: Kwong, Ava, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ukahqfqp32uuju2q1nrfacaitq